The estimated Net Worth of Thomas R Cech is at least $968 mil dollars as of 3 February 2017. Thomas Cech owns over 5,000 units of Merck & Co Inc stock worth over $585,021 and over the last 15 years he sold MRK stock worth over $22,565. In addition, he makes $360,000 as Independent Director at Merck & Co Inc.
Thomas has made over 2 trades of the Merck & Co Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently he exercised 5,000 units of MRK stock worth $175,950 on 3 February 2017.
The largest trade he's ever made was exercising 5,000 units of Merck & Co Inc stock on 3 February 2017 worth over $175,950. On average, Thomas trades about 367 units every 79 days since 2009. As of 3 February 2017 he still owns at least 5,100 units of Merck & Co Inc stock.
You can see the complete history of Thomas Cech stock trades at the bottom of the page.
Dr. Thomas R. Cech, Ph.D. is Independent Director of the Company. Dr. Cech has extensive scientific expertise relevant to the pharmaceutical industry, including being a Nobel Prize-winning chemist and a Professor at the University of Colorado. In addition, his role as the former President of the Howard Hughes Medical Institute provides Dr. Cech with extensive managerial experience with direct relevance to scientific research. University of Colorado ?Distinguished Professor, Chemistry and Biochemistry (1990-present) Director, BioFrontiers Institute (2009-present) Howard Hughes Medical Institute, non-profit medical research organization President (2000-2009) ?Investigator (1988-present).
As the Independent Director of Merck & Co Inc, the total compensation of Thomas Cech at Merck & Co Inc is $360,000. There are 9 executives at Merck & Co Inc getting paid more, with Kenneth Frazier having the highest compensation of $27,648,500.
Thomas Cech is 73, he's been the Independent Director of Merck & Co Inc since 2009. There are no older and 27 younger executives at Merck & Co Inc.
Thomas's mailing address filed with the SEC is UNIVERSITY OF COLORADO, BOULDER, DEPT. OF CHEMISTRY & BIOCHEMISTRY, BOULDER, CO, 80309.
Over the last 15 years, insiders at Merck & Co Inc have traded over $138,980,380 worth of Merck & Co Inc stock and bought 48,209 units worth $1,563,736 . The most active insiders traders include Wendell P Weeks, Kenneth C Frazier y Douglas M Jr Baker. On average, Merck & Co Inc executives and independent directors trade stock every 15 days with the average trade being worth of $5,050,222. The most recent stock trade was executed by Chirfi Guindo on 5 August 2024, trading 36,901 units of MRK stock currently worth $4,250,995.
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey, and is named for Merck Group, founded in Germany in 1668, of whom it was once the American arm. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada.
Merck & Co Inc executives and other stock owners filed with the SEC include: